Asosiy kontentga oʻtish
Maqola

Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

Susan BullmanDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USAChandra Sekhar PedamalluBroad Institute of MIT and Harvard, Cambridge, MA 02142, USAEwa SicińskaDana-Farber Cancer InstituteThomas E. ClancyBrigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USAXiaoyang ZhangDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USADiana CaiDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USADonna NeubergDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USAKatherine HuangBroad Institute of MIT and Harvard, Cambridge, MA 02142, USAFatima GuevaraDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USATimothy NelsonDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USAOtari ChipashviliDana-Farber Cancer InstituteTimothy HaganDana-Farber Cancer InstituteMark WalkerBroad Institute of MIT and Harvard, Cambridge, MA 02142, USAAruna RamachandranDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USABegoña DiosdadoDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USAGarazi SernaVall d'Hebron Institut de RecercaNuria MuletVall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, CIBERONC, Universitat Autònoma de Barcelona, SpainStefania LandolfiVall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, CIBERONC, Universitat Autònoma de Barcelona, SpainSantiago Ramón y CajalVall d'Hebron Institut de RecercaRoberta FasaniVall d'Hebron Institut de RecercaAndrew J. AguirreBrigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USAKimmie NgDana-Farber Cancer InstituteElena ÉlezVall d'Hebron Institut de RecercaShuji OginoBrigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USAJosep TaberneroVall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, CIBERONC, Universitat Autònoma de Barcelona, SpainCharles S. FuchsYale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USAWilliam C. HahnDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USAPaolo NucíforoVall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, CIBERONC, Universitat Autònoma de Barcelona, SpainMatthew MeyersonBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
2017en
ABI

Annotatsiya

Bacteria go the distance in cancer The bacterial species Fusobacterium nucleatum is associated with a subset of human colorectal cancers, but its role in tumorigenesis is unclear. Studying patient samples, Bullman et al. found that F. nucleatum and certain co-occurring bacteria were present not only in primary tumors but also in distant metastases. Preliminary evidence suggests that the bacterium is localized primarily within the metastatic cancer cells rather than in the stroma. Antibiotic treatment of mice carrying xenografts of F. nucleatum –positive human colorectal cancer slowed tumor growth, consistent with a causal role for the bacterium in tumorigenesis. Science , this issue p. 1443

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba